To evaluate possible new drugs for the treatment of Colorectal Carcinoma (CRC) using in silico tools was main objective this study. The method analysis used evaluation tumor markers and their interaction with selected drugs, through study its pharmacokinetic pharmacodynamic characteristics. A potential therapeutic target pointed out Cell Division Cycle 25 B (CDC25B), belonging to CDC25 phosphat...